vs
Falcon's Beyond Global, Inc.（FBYD）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Falcon's Beyond Global, Inc.的1.4倍（$9.1M vs $6.6M），Falcon's Beyond Global, Inc.净利率更高（-4.5% vs -60.3%，领先55.8%），Falcon's Beyond Global, Inc.同比增速更快（383.5% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-4.3M），过去两年Falcon's Beyond Global, Inc.的营收复合增速更高（108.4% vs -6.7%）
500 Global成立于2010年，是一家专注早期投资的风投基金与种子创业加速器，创始人为戴夫·麦克卢尔与蔡金嫺。2011年，该机构先后分三批，共吸纳了67家初创企业入驻其位于加州山景城的孵化办公室。截至2024年3月，500 Global的资产管理规模达23亿美元。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
FBYD vs PLX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.6M | $9.1M |
| 净利润 | $-296.0K | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | -30.9% | -51.1% |
| 净利率 | -4.5% | -60.3% |
| 营收同比 | 383.5% | -49.9% |
| 净利润同比 | 97.5% | -184.8% |
| 每股收益（稀释后） | $-0.01 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $6.6M | $9.1M | ||
| Q3 25 | $4.1M | $17.9M | ||
| Q2 25 | $2.5M | $15.7M | ||
| Q1 25 | $1.7M | $10.1M | ||
| Q4 24 | $1.4M | $18.2M | ||
| Q3 24 | $2.1M | $18.0M | ||
| Q2 24 | $1.8M | $13.5M | ||
| Q1 24 | $1.5M | — |
| Q4 25 | $-296.0K | $-5.5M | ||
| Q3 25 | $-10.4M | $2.4M | ||
| Q2 25 | $25.1M | $164.0K | ||
| Q1 25 | $-8.1M | $-3.6M | ||
| Q4 24 | $-11.9M | $6.5M | ||
| Q3 24 | $39.3M | $3.2M | ||
| Q2 24 | $8.0M | $-2.2M | ||
| Q1 24 | $114.0M | — |
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
| Q4 25 | -30.9% | -51.1% | ||
| Q3 25 | -90.9% | 11.9% | ||
| Q2 25 | -53.0% | 7.5% | ||
| Q1 25 | -371.1% | -41.0% | ||
| Q4 24 | -335.6% | 39.6% | ||
| Q3 24 | -118.9% | 22.2% | ||
| Q2 24 | -195.9% | -18.0% | ||
| Q1 24 | -350.5% | — |
| Q4 25 | -4.5% | -60.3% | ||
| Q3 25 | -256.8% | 13.2% | ||
| Q2 25 | 985.2% | 1.0% | ||
| Q1 25 | -473.8% | -35.8% | ||
| Q4 24 | -871.7% | 35.6% | ||
| Q3 24 | 1899.5% | 18.0% | ||
| Q2 24 | 446.5% | -16.4% | ||
| Q1 24 | 7521.4% | — |
| Q4 25 | $-0.01 | $-0.06 | ||
| Q3 25 | $-0.13 | $0.03 | ||
| Q2 25 | $0.30 | $0.00 | ||
| Q1 25 | $-0.13 | $-0.05 | ||
| Q4 24 | $-0.25 | $0.10 | ||
| Q3 24 | $0.39 | $0.03 | ||
| Q2 24 | $0.00 | $-0.03 | ||
| Q1 24 | $1.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9M | $14.7M |
| 总债务越低越好 | $15.6M | — |
| 股东权益账面价值 | $11.9M | $48.2M |
| 总资产 | $66.7M | $82.3M |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
| Q4 25 | $1.9M | $14.7M | ||
| Q3 25 | $4.3M | $13.6M | ||
| Q2 25 | $26.1M | $17.9M | ||
| Q1 25 | $1.1M | $19.5M | ||
| Q4 24 | $825.0K | $19.8M | ||
| Q3 24 | $828.0K | $27.4M | ||
| Q2 24 | $1.7M | $23.4M | ||
| Q1 24 | $1.1M | — |
| Q4 25 | $15.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $41.2M | — | ||
| Q3 24 | $10.3M | — | ||
| Q2 24 | $15.7M | — | ||
| Q1 24 | $15.1M | — |
| Q4 25 | $11.9M | $48.2M | ||
| Q3 25 | $9.2M | $52.9M | ||
| Q2 25 | $414.0K | $49.9M | ||
| Q1 25 | $-11.6M | $45.2M | ||
| Q4 24 | $-9.0M | $43.2M | ||
| Q3 24 | $-1.4M | $32.4M | ||
| Q2 24 | $-44.7M | $28.6M | ||
| Q1 24 | $-61.7M | — |
| Q4 25 | $66.7M | $82.3M | ||
| Q3 25 | $66.8M | $82.3M | ||
| Q2 25 | $89.2M | $78.5M | ||
| Q1 25 | $56.7M | $73.9M | ||
| Q4 24 | $61.2M | $73.4M | ||
| Q3 24 | $66.5M | $61.6M | ||
| Q2 24 | $65.9M | $91.5M | ||
| Q1 24 | $67.8M | — |
| Q4 25 | 1.31× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.3M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | $1.6M |
| 自由现金流率自由现金流/营收 | -66.0% | 17.8% |
| 资本支出强度资本支出/营收 | 0.3% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
| Q4 25 | $-4.3M | $2.0M | ||
| Q3 25 | $-13.3M | $-3.7M | ||
| Q2 25 | $-7.9M | $-5.2M | ||
| Q1 25 | $945.0K | $-5.1M | ||
| Q4 24 | $-3.8M | $4.0M | ||
| Q3 24 | $-2.4M | $4.1M | ||
| Q2 24 | $-2.6M | $-3.6M | ||
| Q1 24 | $-3.8M | — |
| Q4 25 | $-4.3M | $1.6M | ||
| Q3 25 | $-13.4M | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | $853.0K | $-5.4M | ||
| Q4 24 | $-3.8M | $3.6M | ||
| Q3 24 | $-2.4M | $4.0M | ||
| Q2 24 | $-2.6M | $-3.8M | ||
| Q1 24 | $-3.8M | — |
| Q4 25 | -66.0% | 17.8% | ||
| Q3 25 | -329.6% | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | 49.9% | -53.0% | ||
| Q4 24 | -278.7% | 19.6% | ||
| Q3 24 | -114.9% | 22.4% | ||
| Q2 24 | -145.6% | -28.1% | ||
| Q1 24 | -248.8% | — |
| Q4 25 | 0.3% | 4.4% | ||
| Q3 25 | 1.0% | 2.8% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 5.4% | 3.0% | ||
| Q4 24 | 0.1% | 2.3% | ||
| Q3 24 | 0.2% | 0.5% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | -0.31× | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | -0.06× | 1.27× | ||
| Q2 24 | -0.33× | — | ||
| Q1 24 | -0.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FBYD
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
